MyFinsight
Home
Blog
About
Maturities of investments
$72,983K
(-55.54%↓ Y/Y)
Proceeds from ft819 cirm
award
$1,324K
Issuance of common stock
from equity...
$412K
Net cash provided by
investing activities
$14,557K
(-76.62%↓ Y/Y)
Net cash provided by
financing activities
$1,736K
(31.02%↑ Y/Y)
Canceled cashflow
$58,426K
Net change in cash,
cash equivalents and...
-$7,141K
(-237.51%↓ Y/Y)
Canceled cashflow
$16,293K
Stock-based compensation
$3,518K
(-75.80%↓ Y/Y)
Depreciation and
amortization
$2,780K
(-57.95%↓ Y/Y)
Accounts payable and
accrued expenses
$1,256K
(113.44%↑ Y/Y)
Change in fair value of
stock price...
$580K
(380.19%↑ Y/Y)
Prepaid expenses and
other assets
-$521K
(83.40%↑ Y/Y)
Accounts receivable
-$1K
(99.95%↑ Y/Y)
Purchases of investments
$58,346K
(-41.32%↓ Y/Y)
Purchases of property and
equipment
$80K
(-96.87%↓ Y/Y)
Net cash used in
operating activities
-$23,434K
(59.87%↑ Y/Y)
Canceled cashflow
$8,656K
Net loss
-$30,159K
(57.93%↑ Y/Y)
Accretion and
amortization of premiums and...
$764K
(-60.10%↓ Y/Y)
Right-of-use assets and lease
liabilities, net
-$585K
(52.86%↑ Y/Y)
Deferred revenue
-$582K
(-48.09%↓ Y/Y)
Back
Back
Cash Flow
FATE THERAPEUTICS INC (FATE)
FATE THERAPEUTICS INC (FATE)
source: myfinsight.com